Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 20/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 20/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 20/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 20/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 16/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 16/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 16/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 16/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 16/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 16/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 16/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4308547 | 0.80 | HDAC3 (0.44) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4076375 | 0.78 | HDAC6 (0.41) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4309821 | 0.78 | HDAC3 (0.38) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL1366117 | 0.67 | HDAC1 (0.45) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL3811028 | 0.67 | HDAC1 (0.41) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL2143881 | 0.65 | HDAC3 (0.40) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL18356434 | 0.63 | HDAC1 (0.41) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL1367543 | 0.62 | HDAC6 (0.41) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL1366239 | 0.61 | GPR119 (0.56) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL1366236 | 0.61 | GPR119 (0.56) | HDAC3HDAC1HDAC2HDAC6HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009137503-A1 | HDAC INHIBITORS AND USES THEREOF | ENVIVO PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | claimed |
| EP-2691099-A1 | METHODS OF TARGETED TREATMENT OF FRONTOTEMPORAL LOBAR DEGENERATION | Envivo Pharmaceuticals, Inc. (US) | 2014-02-05 | — | — | EP | disclosed |
| WO-2012135097-A1 | METHODS OF TARGETED TREATMENT OF FRONTOTEMPORAL LOBAR DEGENERATION | ENVIVO PHARMACEUTICALS, INC. (US) | 2012-10-04 | — | — | WO | disclosed |